Consort Medical PLC | Mutual Funds
Mutual Funds that own Consort Medical PLC
Oppenheimer Global Opportunities Fund
2,856,109
5.8%
0
0.46%
03/31/2018
Polar Capital Funds Plc - Healthcare Opportunities Fund
2,255,391
4.58%
198,201
1.93%
07/31/2018
Neptune Investment Funds - UK Mid Cap Fund
1,976,944
4.01%
-797,595
5.03%
06/30/2017
Invesco Perpetual Sm. Cos. & Mkts Invt. Ser-UK Sm. Cos. Eq.
1,342,729
2.72%
86,468
2.21%
03/29/2018
Schroder UTL - UK Smaller Companies Fd.
1,250,000
2.54%
0
2.02%
11/30/2017
Schroder Institutional UK Smaller Companies Fund
1,250,000
2.54%
0
2.06%
05/31/2018
River & Mercantile Funds ICVC - UK Equity Smaller Companies
950,000
1.93%
-250,000
1.3%
09/30/2017
Artemis UK Smaller Companies Fund
948,337
1.92%
26,006
2.13%
06/29/2018
Artemis Strategic Assets Fund
860,000
1.75%
-190,000
1.14%
06/29/2018
Montanaro European Smaller Cos. Plc - European Smaller Cos.
775,000
1.57%
0
1.81%
07/31/2018
| Address |
Breakspear Park
Hemel Hempstead Hertfordshire HP2 4TZ
United Kingdom
|
|
Employees
|
- |
| Website |
http://consortmedical.com |
| Updated |
07/08/2019 |
| Consort Medical Plc engages in the design, development, manufacture, and sale of medical drug delivery devices. It operates through two segments: Bespak and Aesica. The Bespak segment develops and produces drug delivery devices, which serves pharmaceutical companies with inhaler and auto-injector technologies. |
